UniCredit Bonus Zert BNTX 27.06.2.../ DE000HD3TM79 /
2024-09-05 7:04:55 PM | Chg.+0.99 | Bid7:33:18 PM | Ask7:33:18 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
84.61EUR | +1.18% | 84.59 Bid Size: 10,000 |
- Ask Size: - |
BioNTech SE | - USD | 2025-06-27 | Call |
GlobeNewswire
08-29
Advanced Medical Balloons appoints top-performing US life-science executive to drive business growth
GlobeNewswire
08-29
Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform
GlobeNewswire
08-22
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vacc...
GlobeNewswire
08-16
Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and C...
GlobeNewswire
08-14
Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
08-01
Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
07-30
BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patie...
GlobeNewswire
07-22
BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024
GlobeNewswire
06-27
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the E...
GlobeNewswire
06-24
BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT...
GlobeNewswire
06-01
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire
05-29
BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire
05-28
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...
GlobeNewswire
05-21
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire
05-21
Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire
05-17
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire
05-17
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates